Articles with public access mandates - Maen AbdelrahimLearn more
Not available anywhere: 2
1,1‐bis(3′‐indolyl)‐1‐(p‐methoxyphenyl)methane activates Nur77‐independent proapoptotic responses in colon cancer cells
SD Cho, P Lei, M Abdelrahim, K Yoon, S Liu, J Guo, S Papineni, ...
Molecular Carcinogenesis: Published in cooperation with the University of …, 2008
Mandates: US National Institutes of Health
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients
A Abudayyeh, A Hamdi, M Abdelrahim, H Lin, VD Page, G Rondon, ...
Transplant Infectious Disease 19 (1), e12632, 2017
Mandates: US National Institutes of Health
Available somewhere: 42
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
N Abdel-Wahab, H Safa, A Abudayyeh, DH Johnson, VA Trinh, ...
Journal for immunotherapy of cancer 7, 1-10, 2019
Mandates: US National Institutes of Health
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
O Mamlouk, U Selamet, S Machado, M Abdelrahim, WF Glass, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
Mandates: US National Institutes of Health
Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth
SO Lee, M Abdelrahim, K Yoon, S Chintharlapalli, S Papineni, K Kim, ...
Cancer research 70 (17), 6824-6836, 2010
Mandates: US National Institutes of Health
Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3, 11‐dioxo‐18β‐olean‐1, 12‐dien‐30‐oate in colon cancer cells
S Chintharlapalli, S Papineni, M Abdelrahim, A Abudayyeh, I Jutooru, ...
International journal of cancer 125 (8), 1965-1974, 2009
Mandates: US National Institutes of Health
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors
V Nair, S Sreevalsan, R Basha, M Abdelrahim, A Abudayyeh, AR Hoffman, ...
Journal of Biological Chemistry 289 (40), 27692-27701, 2014
Mandates: US National Institutes of Health
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ...
Kidney international 100 (1), 196-205, 2021
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Methyl 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a
I Jutooru, G Chadalapaka, M Abdelrahim, MR Basha, I Samudio, ...
Molecular pharmacology 78 (2), 226-236, 2010
Mandates: US National Institutes of Health
Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2
Y Wang, L Huang, M Abdelrahim, Q Cai, A Truong, R Bick, B Poindexter, ...
Journal of leukocyte biology 86 (4), 981-988, 2009
Mandates: US National Institutes of Health
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met
S Papineni, S Chintharlapalli, M Abdelrahim, S Lee, R Burghardt, ...
Carcinogenesis 30 (7), 1193-1201, 2009
Mandates: US National Institutes of Health
Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors
V Nair, S Pathi, I Jutooru, S Sreevalsan, R Basha, M Abdelrahim, ...
Carcinogenesis 34 (12), 2870-2879, 2013
Mandates: US National Institutes of Health
Specificity protein transcription factors and cancer: opportunities for drug development
S Safe, J Abbruzzese, M Abdelrahim, E Hedrick
Cancer prevention research 11 (7), 371-382, 2018
Mandates: US National Institutes of Health
Activation of nerve growth factor-induced Bα by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth
SD Cho, SO Lee, S Chintharlapalli, M Abdelrahim, S Khan, K Yoon, ...
Molecular pharmacology 77 (3), 396-404, 2010
Mandates: US National Institutes of Health
Nuclear receptor 4A1 (NR4A1) as a drug target for renal cell adenocarcinoma
E Hedrick, SO Lee, G Kim, M Abdelrahim, UH Jin, S Safe, A Abudayyeh
PLoS One 10 (6), e0128308, 2015
Mandates: US National Institutes of Health
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma
RR McMillan, M Javle, S Kodali, A Saharia, C Mobley, K Heyne, ...
American journal of transplantation 22 (3), 823-832, 2022
Mandates: US National Institutes of Health
1,1- Bis (3′-indolyl)-1-( p -substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal …
P Lei, M Abdelrahim, SD Cho, S Liu, S Chintharlapalli, S Safe
Carcinogenesis 29 (6), 1139-1147, 2008
Mandates: US National Institutes of Health
Role of peroxisome proliferator-activated receptor-γ and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia
T Tsao, S Kornblau, S Safe, JC Watt, V Ruvolo, W Chen, Y Qiu, ...
Cancer research 70 (12), 4949-4960, 2010
Mandates: US National Institutes of Health
Symptomatic BK virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients
A Abudayyeh, A Hamdi, H Lin, M Abdelrahim, G Rondon, BS Andersson, ...
American Journal of Transplantation 16 (5), 1492-1502, 2016
Mandates: US National Institutes of Health
Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1, 1-bis (3′-indoly)-1-(p-substituted phenyl) methanes
P Lei, M Abdelrahim, SD Cho, X Liu, S Safe
Molecular cancer therapeutics 7 (10), 3363-3372, 2008
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program